PIM kinase inhibitor, AZD1208, inhibits protein translation and induces autophagy in primary chronic lymphocytic leukemia cells.

Cervantes-Gomez, Fabiola; Stellrecht, Christine M; Ayres, Mary L; Keating, Michael J; Wierda, William G; Gandhi, Varsha.

Afiliação

Cervantes-Gomez F; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Stellrecht CM; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ayres ML; Graduate School of Biomedical Sciences, University of Texas Health Science Center, Houston, TX, USA.
Keating MJ; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Wierda WG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Gandhi V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Oncotarget ; 10(29): 2793-2809, 2019 Apr 19.

Article em En | MEDLINE | ID: mdl-31073371